Tirzepatide 15MG
Tirzepatide 15MG is a 15-milligram format of tirzepatide, a synthetic peptide studied as a dual agonist at the GIP and GLP 1 receptors. It is of interest in metabolic and endocrine research where incretin signaling is examined. Studies have evaluated tirzepatide in preclinical and clinical settings to better understand receptor bias, signaling kinetics, and downstream biomarker changes.
In Stock
Tirzepatide 15MG is a 15-milligram format of tirzepatide, a synthetic peptide investigated as a dual GIP and GLP 1 receptor agonist. Researchers study Tirzepatide 15MG in the context of incretin biology, including how combined receptor engagement may influence signaling profiles in metabolic research models.
Studies have examined tirzepatide for questions related to receptor pharmacology, pathway selectivity, and endocrine biomarker interpretation. Its design as a single peptide with dual incretin receptor activity makes it a common reference compound in experiments comparing mono agonists versus dual agonist approaches.
- Specification: 15MG
This product is intended for laboratory and research purposes only. Not for human consumption.
| Weight | 0.2 kg |
|---|---|
| Dimensions | 5 × 5 × 5 cm |
Related Products
Trenbolone Enanthate 125Mg; Drostanolone Enanthate 125Mg; Testosterone Enanthate 125Mg – 500mg/ml, 10ml is a multi compound anabolic androgenic steroid preparation featuring three long ester derivatives of trenbolone, drostanolone, and testosterone. Researchers may reference this combination when examining androgen receptor driven signaling, ester linked pharmacokinetics, and analytical detection methods in complex steroid mixtures. Studies have also considered how mixed esterified steroids behave in chromatography and mass spectrometry workflows.
In Stock
Trenbolone Base 50mg ml 10ml refers to trenbolone in a 50 mg per mL concentration across a 10 mL format. Trenbolone is a synthetic anabolic androgenic steroid derived from the 19 nor testosterone scaffold. Researchers have used trenbolone as a reference compound in studies involving androgen receptor signaling and anabolic steroid structure activity relationships.
In Stock
Masteron Blend Drostanolone Enanthate 150Mg / Drostanolone Propionate 50Mg 200mg/ml 10 ml is a specified blend of two drostanolone esters in a 10 ml format at 200 mg per ml total concentration. Drostanolone is a synthetic androgen derived from dihydrotestosterone that is studied in androgen receptor and steroid ester pharmacology research. Work in analytical settings commonly examines ester composition, stability, and identity using chromatographic and mass spectrometry methods.
In Stock
Trenbolone Acetate 100Mg; Drostanolone Propionate 100Mg; Testosterone Propionate 100Mg – 300mg/ml, 10ml is a multi compound anabolic androgenic steroid blend specified at 300mg/ml in a 10ml format. Trenbolone acetate is a 19 nor testosterone derivative, while drostanolone and testosterone propionate are DHT derived and testosterone based esters used in androgen research. Researchers may examine combined esterified androgens in models involving receptor binding, anabolic androgenic signaling, and pharmacokinetic comparisons.
In Stock
Tirzepatide 30MG is a 30-milligram format of tirzepatide, a synthetic peptide investigated as a dual GIP and GLP 1 receptor agonist in metabolic research. Studies have examined tirzepatide in the context of incretin signaling, glucose regulation pathways, and energy balance models.
In Stock
Cagrilintide + Semaglutide 10MG is a 10-milligram peptide pair combining cagrilintide, an amylin analogue, with semaglutide, a GLP-1 receptor agonist peptide. Researchers study these peptides in metabolic research, including appetite signaling and glucose regulation pathways. This paired format is used in experimental designs that examine co-agonism and complementary endocrine signaling.
In Stock
Semaglutide 10MG is a 10-milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. Researchers study semaglutide in receptor pharmacology and metabolic signaling research, including models examining appetite regulation and glucose homeostasis. It is also used in assay development and method validation where GLP 1 pathway engagement is of interest.
In Stock
Tirzepatide 20MG is a 20-milligram format of tirzepatide, a synthetic peptide studied as a dual GIP and GLP 1 receptor agonist. Researchers examine tirzepatide in metabolic research, including models related to glycemic regulation, appetite signaling, and energy balance.
In Stock
Semaglutide 2MG is a 2-milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. It is studied in pharmacology and metabolic research as a long acting incretin mimetic. Researchers examine semaglutide in receptor signaling and glucose homeostasis models.
In Stock
Cagrilintide 10MG is a 10-milligram format of cagrilintide, a long acting amylin analogue peptide designed to engage amylin receptor pathways. Researchers study cagrilintide in preclinical and translational settings involving appetite signalling, gastric emptying models, and metabolic regulation.
In Stock
Semaglutide 15MG is a 15-milligram format of semaglutide, a synthetic peptide analogue of the endogenous incretin hormone GLP 1. Researchers study semaglutide as a GLP 1 receptor agonist in models of glucose regulation, appetite signaling, and cardiometabolic physiology.
In Stock
Winstrol 50mg/ml 10ml refers to a 50 milligram per millilitre, 10 millilitre format commonly associated with stanozolol, a synthetic anabolic androgenic steroid. In research settings, stanozolol has been examined for its interactions with androgen receptor signaling and anabolic androgenic structure activity relationships. Studies have also used it as a reference compound in analytical and anti doping method development.
In Stock
